INTI Inet Technologies, Inc.

NSD
$0.10

Inet Technologies, Inc. (INTI) is expected to report earnings on November 12, 2026, after the market close.

Inet Technologies Reported Earnings
Friday, August 14, 2026 · 12:00 AM ET
Earnings Date
Nov 12
Thursday · 4:10 PM ET
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Inet Technologies, Inc.

Inhibitor Therapeutics Inc. is a pharmaceutical development company. It discovers, develops and plans to commercialize therapeutics for cancerous and non-cancerous proliferation disorders. The company's lead product consists of SUBA-Itraconazole, a patented, oral formulation of the currently marketed, well-understood, anti-fungal drug, Itraconazole, for treatment of prostate and lung cancers, which are in clinical stage. Inhibitor Therapeutics Inc., formerly known as HedgePath Pharmaceuticals Inc., is based in Tampa, United States.

Industry

Communications Equipment

Charts powered in part by Lightweight Charts™ by TradingView.